Granted Patent B2

US 12,465,761 · App. 16/269,503 · Granted Nov 11, 2025

Inventors: Paul V. Goode (Round Rock, TX); Virender K. Sharma (Paradise Valley, AZ)

A61N1/36007A61N1/05A61N1/0504A61N1/0509A61N1/0517A61N1/18A61N1/36A61N1/3606A61N1/36157A61N1/36171A61N1/36175A61N1/08A61N1/36071A61N1/36139A61N1/37247A61N1/37288A61N1/3752

Abstract

Claims (16)

1 . A method for increasing an end expiratory pressure of a patient's lower esophageal sphincter (LES) by implanting a stimulation system in the patient, wherein the stimulation system comprises one or more electrodes and a stimulator module comprising a pulse generator and a power source, and wherein the stimulator module is in electrical communication with the one or more electrodes through one or more leads, the method comprising:

implanting the one or more electrodes proximate the LES of the patient;

forming a subcutaneous pocket in the patient;

placing the stimulator module in the subcutaneous pocket, wherein the one or more leads are connected to the stimulator module located in the subcutaneous pocket, and wherein the one or more leads are connected to the one or more electrodes; and

causing the end expiratory pressure of the patient's LES to increase by activating the stimulator module to generate a plurality of electrical pulses, wherein the electrical pulses are defined by parameters comprising a frequency in a range of 1 Hz to 300 Hz, a pulse amplitude in a range of 0.5 mA to 30 mA, a pulse width in a range of around 30 usec to 5 msec, and a session duration in a range of 1 minute to 1 day, and wherein said parameters are adapted to increase the end expiratory pressure of the patient's LES.

2 . The method of claim 1 , wherein the one or more electrodes are placed percutaneously without entering a lumen of the patient's gastric wall.

3 . The method of claim 1 , wherein the one or more electrodes are placed percutaneously in a muscle without entering a lumen of the patient's gastric wall.

4 . The method of claim 1 , further comprising endoscopically visualizing an implantation site by performing gastric insufflations using endoscopy, followed by applying trans-illumination.

5 . The method of claim 1 , wherein each of the one or more electrodes are placed with an orientation perpendicular to a gastrointestinal axis of the patient, wherein the gastrointestinal axis is defined by a length extending from an area proximate a mouth of the patient to an area proximate an anus of the patient.

6 . The method of claim 1 , wherein the one or more electrodes comprise at least two electrodes and wherein the two or more electrodes are positioned parallel to each other with a spacing of approximately 1 cm between any two of the two or more electrodes.

7 . The method of claim 1 , wherein the one or more electrodes are positioned 10 cm or less from a pylorus of the patient.

8 . The method of claim 1 , wherein the frequency is in a range of 2 Hz to 80 Hz and the pulse amplitude is in a range of 2 mA to 15 mA.

9 . The method of claim 1 , wherein each of the frequency, pulse amplitude, pulse width, and session duration is set at an amount that improves the end expiratory pressure of the patient's LES by more than 10% relative to an end expiratory pressure level of the patient's LES before activating the stimulator module.

10 . The method of claim 1 , wherein, after stimulation, the end expiratory pressure of the patient's LES increases more than a residual pressure of the patient's LES.

11 . The method of claim 1 , wherein, three months after initial stimulation, the end expiratory pressure of the patient's LES increases by more than 10% relative to a baseline end expiratory pressure of the patient's LES.

12 . The method of claim 1 , wherein, three months after initial stimulation, the end expiratory pressure of the patient's LES increases by approximately 30% relative to a baseline end expiratory pressure of the patient's LES.

Assignments (3)

Continuity (2)

References Cited (400)